gefitinib
CHEBI:CHEBI_49668
Definition
A member of the class of quinazolines that is quinazoline which is substituted by a (3-chloro-4-fluorophenyl)nitrilo group, 3-(morpholin-4-yl)propoxy group and a methoxy group at positions 4,6 and 7, respectively. An EGFR kinase inhibitor used for the treatment of non-small cell lung cancer.
Chemical Information
- Molecular Formula
- C22H24ClFN4O3
- Molecular Mass
- 446.910
- Charge
- 0
- SMILES
- C1=C(C(=CC=2C1=NC=NC2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4)OC
- InChI
- InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21(20)31-8-2-5-28-6-9-30-10-7-28)22(26-14-25-19)27-15-3-4-18(24)17(23)11-15/h3-4,11-14H,2,5-10H2,1H3,(H,25,26,27)
- InChIKey
- XGALLCVXEZPNRQ-UHFFFAOYSA-N
Alternative Names
- 4-(3'-chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline
- gefitinib
- gefitinibum
- Iressa
- Irressat
- N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamine
- N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine
- ZD 1839
- ZD-1839
- ZD1839
Treatment Applications
-
signet ring lung adenocarcinomaView Disease →
DOID:0080305
-
lung carcinomaView Disease →
DOID:3905
-
lung adenocarcinomaView Disease →
DOID:3910
-
lung large cell carcinomaView Disease →
DOID:4556
-
lung cancerView Disease →
DOID:1324
-
lung non-small cell carcinomaView Disease →
DOID:3908
-
lung benign neoplasmView Disease →
DOID:3683
-
adenosquamous lung carcinomaView Disease →
DOID:4829
-
pulmonary neuroendocrine tumorView Disease →
DOID:5410
-
basaloid lung carcinomaView Disease →
DOID:7045
-
esophagus small cell carcinomaView Disease →
DOID:7134
-
lung clear cell carcinomaView Disease →
DOID:7267
Drug Classification
-
morpholinesView Class →
CHEBI:38785
-
aromatic etherView Class →
CHEBI:35618
-
quinazolinesView Class →
CHEBI:38530
-
secondary amino compoundView Class →
CHEBI:50995
-
tertiary amino compoundView Class →
CHEBI:50996
-
monochlorobenzenesView Class →
CHEBI:83403
-
monofluorobenzenesView Class →
CHEBI:83575
-
t234847
-
t234881
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- DRON_00010000
- 328134
- oboInOwl#hasDbXref
- Wikipedia:Gefitinib
- core#notation
- CHEBI:49668
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 328134
- oboInOwl#hasDbXref
- Wikipedia:Gefitinib
- oboInOwl#hasAlternativeId
- CHEBI:49667
- oboInOwl#id
- CHEBI:49668
- core#notation
- CHEBI:49668
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_74440
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#range
- https://w3id.org/def/predibionto#has_drug_112718
- has_treatment
- http://purl.obolibrary.org/obo/DOID_6313
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect26641
- owl#annotatedSource
- t235247
- owl#someValuesFrom
- t856491